Abstract Details

Title Facial Diplegia and Autoimmune Hepatitis After Pembrolizumab Therapy

Topic Neuromuscular and Clinical Neurophysiology (EMG)

Presentation(s) P6 - (-)

Poster/Presentation
Number 138

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Micah D. Yost, DO PRESENTER	No disclosure on file
Teerin Liewluck, MD, FAAN (Department of Neurology, Mayo Clinic)	Dr. Liewluck has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta Therapeutics. Dr. Liewluck has received publishing royalties from a publication relating to health care.

��ɫ����